ABX Advanced Biochemical Compounds GmbH - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a provider of biochemical compounds that manufactures, develops, and distributes biochemicals for nuclear medicine. The company provides products such as PET and SPECT precursors and reference standards, reagents kits and cassettes, PET precursors and FDG reagents kits, custom synthesis, particularly kits, peptides, HCI and radiotracers, among others. It offers pharmaceutical kits and cassettes, APIs, ammpse triflate, precursors, glucose triflates, talose triflates, and others. ABX provides products scuh as raclopride, tosyl fallypride, desmethoxyfallypride, fluoroethylspiperone, nitromazenil, flumazenil, harmol, harmine and etomidate, among others. The company also offers synthesis modules such as ora neptis mosaic-RS, siemens Explora one, and ORA mosaic-LC and Scintomics, among others. ABX is headquartered in Radeberg, Germany.

ABX Advanced Biochemical Compounds GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Endocyte Enters into Licensing Agreement with ABX 10
Equity Offering 11
Endocyte Raises Funds through Private Placement of Shares and Warrants 11
Endocyte Raises USD4.5 Million in Private Placement of Shares upon Exercise of Warrants 12
ABX Advanced Biochemical Compounds GmbH - Key Competitors 13
ABX Advanced Biochemical Compounds GmbH - Key Employees 14
ABX Advanced Biochemical Compounds GmbH - Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List Of Tables


ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Key Facts 2
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ABX Advanced Biochemical Compounds GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Endocyte Enters into Licensing Agreement with ABX 10
Endocyte Raises Funds through Private Placement of Shares and Warrants 11
Endocyte Raises USD4.5 Million in Private Placement of Shares upon Exercise of Warrants 12
ABX Advanced Biochemical Compounds GmbH, Key Competitors 13
ABX Advanced Biochemical Compounds GmbH, Key Employees 14

List Of Figures


ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

ABX Air Inc - Strategic SWOT Analysis Review

ABX Air Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

mAbxience SA - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Mabxience SA (mAbxience), a subsidiary of Chemo Espana SA, is a biotechnology company that research, develops and manufactures biosimilar monoclonal antibodies. The company develops biosimilars, which are used for the

USD 250 View Report

ABX Advanced Biochemical Compounds GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a provider of biochemical compounds that manufactures, develops, and distributes biochemicals for nuclear medicine. The company

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available